Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer’s disease etiology

Alonso, 2018, Infection of fungi and bacteria in brain tissue from elderly persons and patients with Alzheimer’s disease, Front. Aging Neurosci., 10, 159, 10.3389/fnagi.2018.00159 Alzheimer’s Disease International, 2015. World Alzheimer Report 2015: The Global Impact of Dementia. Alzheimer’s Disease International. Apfalter, 2001, Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens, J. Clin. Microbiol., 39, 519, 10.1128/JCM.39.2.519-524.2001 Asquith, 2011, Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts, PLoS Pathog., 7, 10.1371/journal.ppat.1001339 Baillet, 2015, High chlamydia burden promotes tumor necrosis factor-dependent reactive arthritis in SKG mice, Arthritis Rheumatol, 67, 1535, 10.1002/art.39041 Balducci, 2019, Doxycycline for Alzheimer’s disease: fighting beta-amyloid oligomers and neuroinflammation, Front. Pharmacol., 10, 738, 10.3389/fphar.2019.00738 Balin, 1998, Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain, Med. Microbiol. Immunol., 187, 23, 10.1007/s004300050071 Bancher, 1989, Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid beta-protein, Neurobiol. Aging, 10, 125, 10.1016/0197-4580(89)90021-3 Beagley, 2009, Chlamydial infection of immune cells: altered function and implications for disease, Crit. Rev. Immunol., 29, 275, 10.1615/CritRevImmunol.v29.i4.10 Beckett, 2012, TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life, PLoS ONE, 7, 10.1371/journal.pone.0039460 Boelen, 2007, Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection, Acta Neuropathol., 114, 255, 10.1007/s00401-007-0252-3 Boelen, 2007, Inflammatory responses following Chlamydia pneumoniae infection of glial cells, Eur. J. Neurosci., 25, 753, 10.1111/j.1460-9568.2007.05339.x Bohm, 2015, Current and future implications of basic and translational research on amyloid-beta peptide production and removal pathways, Mol. Cell. Neurosci., 66, 3, 10.1016/j.mcn.2015.02.016 Bu, 2015, A study on the association between infectious burden and Alzheimer’s disease, Eur. J. Neurol., 22, 1519, 10.1111/ene.12477 Cai, 2001, BACE1 is the major beta-secretase for generation of Abeta peptides by neurons, Nat. Neurosci., 4, 233, 10.1038/85064 Carter, 2017, Genetic, transcriptome, proteomic, and epidemiological evidence for blood-brain barrier disruption and polymicrobial brain invasion as determinant factors in Alzheimer’s disease, J. Alzheimers Dis. Rep., 1, 125, 10.3233/ADR-170017 Chernesky, 2002, Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories, J. Clin. Microbiol., 40, 2357, 10.1128/JCM.40.7.2357-2362.2002 Cline, 2018, The amyloid-beta oligomer hypothesis: beginning of the third decade, J. Alzheimers Dis., 64, S567, 10.3233/JAD-179941 Cook, 1998, Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project, Stroke, 29, 404, 10.1161/01.STR.29.2.404 Dreses-Werringloer, 2009, Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain, Int. J. Med. Microbiol., 299, 187, 10.1016/j.ijmm.2008.07.002 Dupont, 1990, Power and sample size calculations. A review and computer program, Control. Clin. Trials, 11, 116, 10.1016/0197-2456(90)90005-M Dyrks, 1993, Amyloidogenicity of rodent and human beta A4 sequences, FEBS Lett., 324, 231, 10.1016/0014-5793(93)81399-K Ecemis, 2010, Seroprevalance of Chlamydophila pneumoniae in patients with Alzheimer’s disease and vascular dementia, J Neurol Sci Turk, 27, 400 Eimer, 2018, Alzheimer’s disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection, Neuron, 99 Elargoubi, 2013, Acute encephalitis associated to a respiratory infection due to Chlamydophila pneumoniae, Med. Mal. Infect., 43, 345, 10.1016/j.medmal.2013.06.015 Elkind, 2000, Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study, Stroke, 31, 1521, 10.1161/01.STR.31.7.1521 Emery, 2017, 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain, Front. Aging Neurosci., 9, 195, 10.3389/fnagi.2017.00195 Esquerda-Canals, 2017, Mouse models of Alzheimer’s disease, J. Alzheimers Dis., 57, 1171, 10.3233/JAD-170045 Essilfie, 2015, Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma, Thorax, 70, 458, 10.1136/thoraxjnl-2014-206067 Farrall, 2009, Blood-brain barrier: ageing and microvascular disease–systematic review and meta-analysis, Neurobiol. Aging, 30, 337, 10.1016/j.neurobiolaging.2007.07.015 Frackowiak, 2013, The link between intraneuronal N-truncated amyloid-beta peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism, Acta Neuropathol. Commun., 1, 61, 10.1186/2051-5960-1-61 Fung, 2013, Interferon-epsilon protects the female reproductive tract from viral and bacterial infection, Science, 339, 1088, 10.1126/science.1233321 George, 2019, No Association Found Between Midlife Seropositivity for Infection and Subsequent Cognitive Decline: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS), J. Geriatr. Psychiatry Neurol. Gerard, 2006, Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain, FEMS Immunol. Med. Microbiol., 48, 355, 10.1111/j.1574-695X.2006.00154.x Gerard, 2008, Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells, Microb. Pathog., 44, 279, 10.1016/j.micpath.2007.10.002 Gerard, 2005, The load of Chlamydia pneumoniae in the Alzheimer’s brain varies with APOE genotype, Microb. Pathog., 39, 19, 10.1016/j.micpath.2005.05.002 Giau, 2015, Role of apolipoprotein E in neurodegenerative diseases, Neuropsychiatr. Dis. Treat., 11, 1723, 10.2147/NDT.S84266 Gieffers, 2000, Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer’s disease patients, J. Clin. Microbiol., 38, 881, 10.1128/JCM.38.2.881-882.2000 Gouras, 2002, Generation and regulation of β-amyloid peptide variants by neurons, J. Neurochem., 71, 1920, 10.1046/j.1471-4159.1998.71051920.x Gramegna, 2018, Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective, BMC Infect. Dis., 18, 677, 10.1186/s12879-018-3565-z Hammerschlag, 2002, The intracellular life of chlamydiae, Semin. Pediatr. Infect. Dis., 13, 239, 10.1053/spid.2002.127201 Hammond, 2010, Immunohistological detection of Chlamydia pneumoniae in the Alzheimer’s disease brain, BMC Neurosci., 11, 121, 10.1186/1471-2202-11-121 Hansbro, 2004, Role of atypical bacterial infection of the lung in predisposition/protection of asthma, Pharmacol. Ther., 101, 193, 10.1016/j.pharmthera.2003.10.007 Harper, 1997, Observation of metastable Abeta amyloid protofibrils by atomic force microscopy, Chem. Biol., 4, 119, 10.1016/S1074-5521(97)90255-6 He, 2010, Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome, J. Immunol., 184, 5743, 10.4049/jimmunol.0903937 Head, 2017, Atypical bacterial pneumonia in the HIV-infected population, Pneumonia (Nathan), 9, 12, 10.1186/s41479-017-0036-z Horvat, 2007, Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease, Am. J. Respir. Crit. Care Med., 176, 556, 10.1164/rccm.200607-1005OC Horvat, 2010, Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology, J. Allergy Clin. Immunol., 125, 10.1016/j.jaci.2009.10.018 Ikejima, 2006, Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease, J. Med. Microbiol., 55, 947, 10.1099/jmm.0.46348-0 Itzhaki, 2016, Microbes and Alzheimer’s disease, J. Alzheimers Dis., 51, 979, 10.3233/JAD-160152 Iwatsubo, 1995, Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome, Ann. Neurol., 37, 294, 10.1002/ana.410370305 Jankowsky, 2004, Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase, Hum. Mol. Genet., 13, 159, 10.1093/hmg/ddh019 Kaiko, 2008, Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity, J. Immunol., 180, 2225, 10.4049/jimmunol.180.4.2225 Kim, 2017, MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2, J. Allergy Clin. Immunol., 139, 519, 10.1016/j.jaci.2016.04.038 Kim, 2017, Role for NLRP3 Inflammasome-mediated, IL-1beta-Dependent Responses in Severe, Steroid-Resistant Asthma, Am. J. Respir. Crit. Care Med., 196, 283, 10.1164/rccm.201609-1830OC Koh, 2006, Structural analysis of amyloid aggregates by multifunctional fluorescence nanoscopy, Curr. Appl Phys., 6, e257, 10.1016/j.cap.2006.01.051 Koskiniemi, 1996, Chlamydia pneumoniae associated with central nervous system infections, Eur. Neurol., 36, 160, 10.1159/000117235 Kumar, 2016, Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease, Sci. Transl. Med., 8, 340ra372, 10.1126/scitranslmed.aaf1059 Kuo, 1995, Chlamydia pneumoniae (TWAR), Clin. Microbiol. Rev., 8, 451, 10.1128/CMR.8.4.451 Lim, 2014, Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer’s disease, J. Neuroinflammation, 11, 217, 10.1186/s12974-014-0217-0 Lippa, 1998, Abeta-42 deposition precedes other changes in PS-1 Alzheimer’s disease, Lancet, 352, 1117, 10.1016/S0140-6736(05)79757-9 Little, 2005, Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice, Infect. Immun., 73, 1723, 10.1128/IAI.73.3.1723-1734.2005 Little, 2004, Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice, Neurobiol. Aging, 25, 419, 10.1016/S0197-4580(03)00127-1 Little, 2014, Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae, Front. Aging Neurosci., 6, 304, 10.3389/fnagi.2014.00304 Loeb, 2004, A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease, J. Am. Geriatr. Soc., 52, 381, 10.1111/j.1532-5415.2004.52109.x MacIntyre, 2003, Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells, J. Neurosci. Res., 71, 740, 10.1002/jnr.10519 MacIntyre, 2002, Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells, FEMS Microbiol. Lett., 217, 167, 10.1111/j.1574-6968.2002.tb11470.x Maezawa, 2008, Congo red and thioflavin-T analogs detect Abeta oligomers, J. Neurochem., 104, 457 Mahony, 2000, Identification of chlamydia pneumoniae in the Alzheimer’s brain, Neurobiol. Aging, 21, 245, 10.1016/S0197-4580(00)83440-5 Mann, 1988, The site of the earliest lesions of Alzheimer's disease, N. Engl. J. Med., 318, 789, 10.1056/NEJM198803243181218 Masliah, 1997, Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE, Brain Res., 751, 307, 10.1016/S0006-8993(96)01420-5 Masters, 2015, Alzheimer’s disease, Nat. Rev. Dis. Primers, 1, 15056, 10.1038/nrdp.2015.56 Mawanda, 2013, Can infections cause Alzheimer’s disease?, Epidemiol. Rev., 35, 161, 10.1093/epirev/mxs007 Meyer-Luehmann, 2008, Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease, Nature, 451, 720, 10.1038/nature06616 Moir, 2018, The antimicrobial protection hypothesis of Alzheimer’s disease, Alzheimers Dement., 14, 1602, 10.1016/j.jalz.2018.06.3040 Molloy, 2013, A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer’s disease: the DARAD trial, Int. J. Geriatr. Psychiatry, 28, 463, 10.1002/gps.3846 Nelson, 2012, Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature, J. Neuropathol. Exp. Neurol., 71, 362, 10.1097/NEN.0b013e31825018f7 Newcombe, 2018, Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease, J. Neuroinflammation, 15, 276, 10.1186/s12974-018-1313-3 Nochlin, 1999, Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease, Neurology, 53, 1888, 10.1212/WNL.53.8.1888-a Olivares-Zavaleta, 2011, Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways, J. Immunol., 186, 7120, 10.4049/jimmunol.1100393 Oryshkevich, 1992, Allergic rhinitis, N. Engl. J. Med., 326, 576, 10.1056/NEJM199202203260817 Paldanius, 2005, Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland, Clin. Diagn. Lab. Immunol., 12, 654, 10.1128/CDLI.12.5.654-659.2005 Paradowski, 2007, Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer’s disease and vascular dementia, J. Neurol., 254, 154, 10.1007/s00415-006-0298-5 Pisa, 2017, Polymicrobial infections in brain tissue from Alzheimer’s disease patients, Sci. Rep., 7, 5559, 10.1038/s41598-017-05903-y Potluri, 2015, Genomic DNA extraction methods using formalin-fixed paraffin-embedded tissue, Anal. Biochem., 486, 17, 10.1016/j.ab.2015.06.029 Qosa, 2016, Effect of mouse strain as a background for Alzheimer’s disease models on the clearance of amyloid-beta, J. Syst. Integr. Neurosci., 2, 135, 10.15761/JSIN.1000123 Ring, 2000, Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer’s brain, J. Clin. Microbiol., 38, 2591, 10.1128/JCM.38.7.2591-2594.2000 Roher, 1986, Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein, Proc. Natl. Acad. Sci. U.S.A., 83, 2662, 10.1073/pnas.83.8.2662 Roulis, 2015, Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissues, Genomics, 106, 373, 10.1016/j.ygeno.2015.09.008 Sasaguri, 2017, APP mouse models for Alzheimer’s disease preclinical studies, EMBO J., 36, 2473, 10.15252/embj.201797397 Sessa, 2009, Chlamydia pneumoniae and atherosclerosis: current state and future prospectives, Int.. J. Immunopathol. Pharmacol., 22, 9, 10.1177/039463200902200102 Sipe, 2016, Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines, Amyloid, 23, 209, 10.1080/13506129.2016.1257986 Skelding, 2006, Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection, Vaccine, 24, 355, 10.1016/j.vaccine.2005.07.104 Soscia, 2010, The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide, PLoS ONE, 5, 10.1371/journal.pone.0009505 Sriram, 2002, Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis, Clin. Diagn. Lab. Immunol., 9, 1332 Starkey, 2013, Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease, Mucosal Immunol., 6, 569, 10.1038/mi.2012.99 Sun, 2009, Improving the specificity of immunological detection in aged human brain tissue samples, Int. J. Physiol. Pathophysiol. Pharmacol., 2, 29 Sundelof, 1993, An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum, Scand. J. Infect. Dis., 25, 259, 10.3109/00365549309008494 Takahashi, 1993, Monoclonal antibody to beta peptide, recognizing amyloid deposits, neuronal cells and lipofuscin pigments in systemic organs, Acta Neuropathol., 85, 159, 10.1007/BF00227763 Talamo, 1991, Pathologic changes in olfactory neurons in Alzheimer's disease, Ann. N. Y. Acad. Sci., 640, 1, 10.1111/j.1749-6632.1991.tb00182.x Tang, 2009, Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls, PLoS ONE, 4, 10.1371/journal.pone.0005200 Taylor, 2002, Failure to correlate C. pneumoniae with late onset Alzheimer’s disease, Neurology, 59, 142, 10.1212/WNL.59.1.142 Valade, 2018, Severe atypical pneumonia in critically ill patients: a retrospective multicenter study, Ann. Intensive Care, 8, 81, 10.1186/s13613-018-0429-z van Groen, 2006, Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice, Neurobiol. Dis., 23, 653, 10.1016/j.nbd.2006.05.010 Voorend, 2010, Chlamydia pneumoniae infection enhances microglial activation in atherosclerotic mice, Neurobiol. Aging, 31, 1766, 10.1016/j.neurobiolaging.2008.09.022 Wimmer, 1996, Association of chlamydial infection with cerebrovascular disease, Stroke, 27, 2207, 10.1161/01.STR.27.12.2207 Wozniak, 2003, Absence of Chlamydia pneumoniae in brain of vascular dementia patients, Neurobiol. Aging, 24, 761, 10.1016/S0197-4580(02)00236-1 Wright, 2015, Infectious burden and cognitive decline in the Northern Manhattan Study, J. Am. Geriatr. Soc., 63, 1540, 10.1111/jgs.13557 Wynne, 2011, Early life infection alters adult BALB/c hippocampal gene expression in a sex specific manner, Stress, 14, 247, 10.3109/10253890.2010.532576 Xavier, 2005, Sudden psychotic episode probably due to meningoencephalitis and Chlamydia pneumoniae acute infection, Clin. Pract. Epidemiol. Ment. Health, 1, 15, 10.1186/1745-0179-1-15 Xu, 2015, Murine Abeta over-production produces diffuse and compact Alzheimer-type amyloid deposits, Acta Neuropathol. Commun., 3, 72, 10.1186/s40478-015-0252-9 Yamamoto, 2005, High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia, J. Am. Geriatr. Soc., 53, 583, 10.1111/j.1532-5415.2005.53204.x Yang, 1996, Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection, J. Immunol., 156, 4338, 10.4049/jimmunol.156.11.4338 Yook, 2018, Laboratory investigation of trends in bacterial pneumonia in Cheonan, Korea, from january 2008 to september 2017, J. Microbiol. Biotechnol., 28, 1730, 10.4014/jmb.1804.04004 Yulug, 2018, Therapeutic role of rifampicin in Alzheimer’s disease, Psychiatry Clin. Neurosci., 72, 152, 10.1111/pcn.12637